Evaluation of hepatitis B and C viral markers: Clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America

被引:52
作者
Hwang, SJ
Tong, MJ
Lai, PP
Ko, ES
Co, RL
Chien, D
Kuo, G
机构
[1] HUNTINGTON MEM HOSP, CTR LIVER, PASADENA, CA 91105 USA
[2] CHIRON CORP, EMERYVILLE, CA 94608 USA
关键词
antibody to hepatitis C virus; Asian-Americans; Caucasians; hepatitis B surface antigen; hepatocellular carcinoma;
D O I
10.1111/j.1440-1746.1996.tb00279.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In order to evaluate the roles of hepatitis B virus (HBV) and hepatitis C virus (HCV) and their clinical significance in Asian-American and Caucasian patients with hepatocellular carcinoma (HCC) in the USA, 110 HCC patients, seen in a community-based teaching hospital in the Los Angeles area over a 10 year period, were enrolled. Seventy-nine (72%) patients were Asian-Americans and 31 (28%) were Caucasians. Of the 110 HCC patients, 69 (63%) were positive for serum hepatitis B surface antigen (HBsAg), 26 (24%) were positive for serum antibody to hepatitis C virus (anti-HCV), five (all Asian-Americans) were positive for both markers; 11 (10%) patients had a history of alcoholism. HBsAg was detected in 63 (80%) Asian-American patients, significantly higher than in the six (19%) Caucasian HCC patients (P < 0.01). Anti-HCV was detected in 10 (32%) Caucasian and in 16 (20%) Asian-American HCC patients (P > 0.05). Among Asian-American HCC patients, anti-HCV was more prevalent in those who were HBsAg-negative than in the HBsAg-positive patients (69 vs 8%; P < 0.01). A history of alcoholism was obtained in nine (29%) Caucasian HCC patients, significantly higher than in the two (3%) Asian-American HCC patients (P < 0.05). Comparing HCC patients with positive HBsAg and with anti-HCV, HBsAg-positive HCC patients were younger, Asian-Americans and predominantly male; 38% had a family history of liver disease. In contrast, anti-HCV-positive HCC patients were older by nearly a decade and 46% had a history of blood transfusion. Using a stepwise logistic regression analysis, Asian race and patient age < 50 years were found to be independent predictors for HBsAg-positivity, while a history of blood transfusion was the only predictor for anti-HCV-positivity in HCC patients. There was no significant difference in the rate of cirrhosis, serum levels of alpha-fetoprotein and survival between HBsAg-positive and an ti-HCV-positive HCC patients. In conclusion, chronic HBV infection was the major aetiological factor in Asian-American HCC patients, while chronic HCV infection and alcoholism were major aetiological factors in Caucasian HCC patients in the USA.
引用
收藏
页码:949 / 954
页数:6
相关论文
共 41 条
[1]  
BARKER JC, 1992, WESTERN J MED, V157, P248
[2]   POSTNATAL INFECTIVITY OF HEPATITIS-B SURFACE ANTIGEN-CARRIER MOTHERS [J].
BEASLEY, RP ;
HWANG, LY .
JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (02) :185-190
[3]  
BEASLEY RP, 1981, LANCET, V2, P1129
[4]  
BRUIX J, 1989, LANCET, V2, P1004
[5]   HEALTH-STATUS OF REFUGEES FROM VIETNAM, LAOS, AND CAMBODIA [J].
CATANZARO, A ;
MOSER, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (09) :1303-1308
[6]   HEPATITIS-C VIRUS-INFECTION IN AN AREA HYPERENDEMIC FOR HEPATITIS-B AND CHRONIC LIVER-DISEASE - THE TAIWAN EXPERIENCE [J].
CHEN, DS ;
KUO, GC ;
SUNG, JL ;
LAI, MY ;
SHEU, JC ;
CHEN, PJ ;
YANG, PM ;
HSU, HM ;
CHANG, MH ;
CHEN, CJ ;
HAHN, LC ;
CHOO, QL ;
WANG, TH ;
HOUGHTON, M .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (04) :817-822
[7]   DIAGNOSIS OF HEPATITIS-C VIRUS (HCV) INFECTION USING AN IMMUNODOMINANT CHIMERIC POLYPROTEIN TO CAPTURE CIRCULATING ANTIBODIES - REEVALUATION OF THE ROLE OF HCV IN LIVER-DISEASE [J].
CHIEN, DY ;
CHOO, QL ;
TABRIZI, A ;
KUO, C ;
MCFARLAND, J ;
BERGER, K ;
LEE, C ;
SHUSTER, JR ;
NGUYEN, T ;
MOYER, DL ;
TONG, M ;
FURUTA, S ;
OMATA, M ;
TEGTMEIER, G ;
ALTER, H ;
SCHIFF, E ;
JEFFERS, L ;
HOUGHTON, M ;
KUO, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10011-10015
[8]  
DIBISCEGLIE AM, 1991, AM J GASTROENTEROL, V86, P335
[9]  
FURUTA T, 1990, CANCER-AM CANCER SOC, V66, P2395, DOI 10.1002/1097-0142(19901201)66:11<2395::AID-CNCR2820661125>3.0.CO
[10]  
2-T